Ellevest, Inc. Veracyte, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$20.58 - $27.89 $905 - $1,227	44 Added 37.93%	160 $3,000
Q4 2022 Feb 03, 2023	BUY	$15.31 - $29.94 $1,607 - $3,143	105 Added 954.55%	116 $2,000
Q3 2022 Nov 02, 2022	BUY	$16.58 - $27.9 $182 - $306	11 New	11 $0
Q2 2021 Jul 13, 2021	SELL	$32.94 - $56.62 $428 - $736	-13 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$44.47 - $81.38 $578 - $1,057	13 New	13 $1,000

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.